-
公开(公告)号:US09371374B2
公开(公告)日:2016-06-21
申请号:US14138991
申请日:2013-12-23
申请人: Abbott Laboratories
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/569 , C07K16/10 , G01N33/576
CPC分类号: G01N33/5767 , C07K16/109 , C07K2317/34 , C07K2317/56 , C07K2317/92 , G01N2333/186 , G01N2469/10 , G01N2800/52
摘要: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
摘要翻译: 本发明涉及用于检测HCV抗原的单克隆抗体。 更具体地,本发明描述了用于检测HCV感染的抗HCV核心抗原脂质结合结构域和免疫测定方法,试剂盒和组合物的抗体。
-
公开(公告)号:US10345311B2
公开(公告)日:2019-07-09
申请号:US15189638
申请日:2016-06-22
申请人: ABBOTT LABORATORIES
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: A61K39/00 , G01N33/576 , C07K16/10
摘要: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
-
3.
公开(公告)号:US20230258638A1
公开(公告)日:2023-08-17
申请号:US18045845
申请日:2022-10-12
申请人: Abbott Laboratories
发明人: A. Scott Muerhoff , John C. Prostko , James L. Stewart , Mary A. RODGERS , Gavin A. CLOHERTY , James Hartnett , Jeff Moore , Kathy Otis , Alak Kar , Bailin Tu , Bryan Tieman , Carolyn Strobel , David Hawksworth , Robert Ziemann , Zhihong Lin , Chris Marohnic , Peter Wiebe , Todd Meyer , Weijie Jiao , Gangamani S. Beligere , Saminathan X. Muthusamy , Jessica L. Grieshaber , Sandra K. Pearce , Edwin C. Frias , Russell E. Taylor , Kelly Coller , Yangrong E. Zhang , Thomas T. Biegalski , David J. Daghfal , Claudio Galli , Sergey Y. Tetin , Qiaoqiao Ruan , Patrick MacDonald , Michael S. Cassidy , Mary E. Gardiner , Mary Ann P. Palafox , Matthew S. Matias , Melissa B. Brennan , Philip W. Schultz , Beth C. Trudeau
IPC分类号: G01N33/569
CPC分类号: G01N33/56983 , G01N2333/165 , G01N2469/20 , G01N2800/52
摘要: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an antibody against at least one type of β-coronavirus, such as, for example, an antibody against SARS-CoV or SARS-CoV-2, in one or more samples obtained from a subject. In some aspects, the methods, kits and systems relate to detecting the presence of or determining an amount, quantity, concentration and/or level of at least one type of anti-β-coronavirus antibody, such as an IgG and/or IgM antibody, in one or more samples obtained from a subject. The methods, kits systems, algorithms and improvements can also be used to monitor a subject's response and/or treatment to a β-coronavirus, determine whether or not a subject will develop or experience a cytokine storm, predict outcome in a subject, determine whether a subject can be administered a vaccine for a β-coronavirus, monitoring antibody response in individuals that have received a β-coronavirus vaccine (such as a SARS-CoV-2 vaccine), and/or determine the immune status of a subject.
-
公开(公告)号:US20140272931A1
公开(公告)日:2014-09-18
申请号:US14138991
申请日:2013-12-23
申请人: Abbott Laboratories
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/569 , C07K16/10
CPC分类号: G01N33/5767 , C07K16/109 , C07K2317/34 , C07K2317/56 , C07K2317/92 , G01N2333/186 , G01N2469/10 , G01N2800/52
摘要: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
摘要翻译: 本发明涉及用于检测HCV抗原的单克隆抗体。 更具体地,本发明描述了用于检测HCV感染的抗HCV核心抗原脂质结合结构域和免疫测定方法,试剂盒和组合物的抗体。
-
公开(公告)号:US11428694B2
公开(公告)日:2022-08-30
申请号:US17231782
申请日:2021-04-15
申请人: Abbott Laboratories
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/576 , C07K16/00 , C07K16/10
摘要: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
-
6.
公开(公告)号:US20200033344A1
公开(公告)日:2020-01-30
申请号:US16539742
申请日:2019-08-13
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis , Andrea Branch , Francis Eng
IPC分类号: G01N33/576 , C07K16/10
摘要: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.
-
公开(公告)号:US10444242B2
公开(公告)日:2019-10-15
申请号:US15189646
申请日:2016-06-22
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis , Andrea Branch , Francis Eng
IPC分类号: G01N33/576 , C07K16/10
摘要: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies or antibody fragments. In certain embodiments, the lipid binding domain monoclonal antibody or antibody fragment recognizes an epitope in amino acids 141 to 161 of HCV core protein and the DNA binding domain antibody or antibody fragment recognizes an epitope in amino acids 95-123 (e.g., in amino acids 99-117) of HCV core protein.
-
公开(公告)号:US20210231665A1
公开(公告)日:2021-07-29
申请号:US17231782
申请日:2021-04-15
申请人: Abbott Laboratories
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/576 , C07K16/10
摘要: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
-
公开(公告)号:US10197573B2
公开(公告)日:2019-02-05
申请号:US15079013
申请日:2016-03-23
申请人: ABBOTT LABORATORIES
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/576 , C07K16/10
摘要: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
-
公开(公告)号:US20160291020A1
公开(公告)日:2016-10-06
申请号:US15079013
申请日:2016-03-23
申请人: ABBOTT LABORATORIES
发明人: Robert Ziemann , April Ahlberg , David Hawksworth , Bryan Tieman , A. Scott Muerhoff , Christopher Marohnic , Kathy Otis
IPC分类号: G01N33/576 , C07K16/10
CPC分类号: G01N33/5767 , C07K16/109 , C07K2317/34 , C07K2317/56 , C07K2317/92 , G01N2333/186 , G01N2469/10 , G01N2800/52
摘要: The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
摘要翻译: 本发明涉及用于检测HCV抗原的单克隆抗体。 更具体地,本发明描述了用于检测HCV感染的抗HCV核心抗原脂质结合结构域和免疫测定方法,试剂盒和组合物的抗体。
-
-
-
-
-
-
-
-
-